Northwestern Mutual Wealth Management
CMMB

Northwestern Mutual Wealth Management’s Chemomab Therapeutics CMMB Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio CMMB Stock Details CMMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2
Closed -$3 – 4187
2025
Q4 		$3 Buy
+2
New +$5 ﹤0.01% 3985

Other funds holding CMMB

ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
KPWS
Kestra Private Wealth Services Austin, Texas $8.11B AUM 24.74% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
SP
SmartHarvest Portfolios Poulsbo, Washington $240M AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
PIP
Philadelphia Investment Partners Voorhees, New Jersey $147M AUM

Northwestern Mutual Wealth Management's CMMB Position: Q1 2026 in Review

Northwestern Mutual Wealth Management sold out of Chemomab Therapeutics (CMMB) in Q1 2026, closing a stake of 2 shares — an estimated $3 sold.

Northwestern Mutual Wealth Management first reported a position in CMMB in Q4 2025 and held it in 1 quarter. The position peaked at $3 in Q4 2025. 15 funds tracked by Wall St. Rank hold CMMB as of Q1 2026.

  • Northwestern Mutual Wealth Management reported no remaining Chemomab Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Northwestern Mutual Wealth Management sold 2 Chemomab Therapeutics shares in Q1 2026, an estimated $3.
  • Northwestern Mutual Wealth Management first reported a position in Chemomab Therapeutics in Q4 2025 and held it in 1 quarter.
  • Northwestern Mutual Wealth Management's Chemomab Therapeutics position peaked at $3 in Q4 2025.
  • 15 funds tracked by Wall St. Rank held Chemomab Therapeutics as of Q1 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q1 2026, filed 7 May 2026.